Rocket Pharmaceuticals (RCKT) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

RCKT is expected to report earnings to rise 1.54% to -75 cents per share on November 06

Rocket Pharmaceuticals RCKT Stock Earnings Reports

Q3'24

Est.

$-0.75

Q2'24

Missed

by $0.02

Q1'24

Beat

by $0.01

Q4'23

Beat

by $0.14

Q3'23

Beat

by $0.06

The last earnings report on August 05 showed earnings per share of -74 cents, missing the estimate of -72 cents. With 998.25K shares outstanding, the current market capitalization sits at 1.68B.

View a ticker or compare two or three

Compare

RCKT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For RCKT
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for RCKT (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a provider of gene therapy services

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

9 Cedarbrook Drive

Phone

+1 609 659-8001

Employees

268

Web

https://www.rocketpharma.com